Mars Petcare settles with Federal Trade Commission
Legal order would bar claims that pet food extends animals’ lives
Mars Petcare US, Inc., has agreed to settle Federal Trade Commission charges that it falsely advertised the health benefits of its Eukanuba brand dog food. Specifically, the FTC alleges that the company claimed, but could not prove, that a 10-year study found that dogs fed Eukanuba could extend their expected lifespan by 30 percent or more.
“Pet owners count on ads to be truthful and not to misrepresent health-related benefits,” said Jessica Rich, Director of the FTC’s Bureau of Consumer Protection in a press release. “In this case, Mars Petcare simply did not have the evidence to back up the life-extending claims it made about its Eukanuba dog food.”
The ads in question
According to the FTC’s complaint, in 2015, Mars Petcare ran ads for Eukanuba on television, in print, and on the Internet, claiming that the dog food could increase the longevity of dogs’, based on a 10-year study of dogs that were fed Eukanuba and implying that the increase in lifespan was 30 percent or more.
One TV ad stated, for example:
“10 years ago, we launched a long life study. What we observed was astonishing. With Eukanuba and proper care, dogs in the study were able to live beyond their typical lifespan.” The ad then showed a dog named “Iowa” who was 17 years old, while “the typical Labrador lifespan: [is] 12 years.” The implication was that Iowa had lived 30 percent longer than expected for her breed because she was fed Eukanuba.
The FTC alleges that the longevity claims are false or unsubstantiated and that the claim that longevity was proven through scientific evidence is false.
Consequences for Mars Petcare
The proposed order settling the FTC’s charges prohibits Mars Petcare from engaging in similar deceptive acts or practices in the future. First, it prohibits the company from making any misleading or unsubstantiated claims that its Eukanuba-brand pet food or any other pet food will enable any dogs to extend their lifespan by 30 percent or more or live exceptionally long lives. It also prohibits the company from making misleading or unsubstantiated claims regarding the health benefits of any pet food, and requires the company to have competent and reliable scientific evidence to back up any such claims.
Finally, the proposed order prohibits Mars Petcare, when advertising any pet food, from misrepresenting the existence, results, conclusions, or interpretations of any study, or falsely stating that the health benefits claimed are scientifically proven. It also contains compliance and monitoring requirements to ensure the company abides by its terms.
The agreement will be subject to public comment for 30 days, beginning today and continuing through September 6, 2016, after which the Commission will decide whether to make the proposed consent order final. Interested parties can submit comments electronically by following the instructions in the “Invitation to Comment” part of the “Supplementary Information” section of the Federal Register notice.